Image Credit: Canva
A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.
Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.
The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.
Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.
Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.
Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.
Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.
These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.
Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:
Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.
Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.
Blood Tests: High levels of HGA in the blood can be used as further evidence.
Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.
At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:
Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.
Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.
Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.
Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.
Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.
Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.
Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.
As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.
Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.
Credit: X
Catherine, Princess of Wales, recently opened up about her cancer recovery. In an interview, the Princess, widely known as Kate Middleton, spoke about how nature helped her navigate the physical and emotional challenges of her illness. She said that spending time outdoors became an integral part of her cancer recovery.
Her experience adds to the growing research into how exposure to natural environments may help the well-being of people battling cancer.
Kate announced her cancer diagnosis in March 2024 and said she was undergoing preventive chemotherapy. She completed treatment in September 2024 and announced in January 2025 that she was in remission. She did not publicly disclose the type of cancer she was diagnosed with.
Speaking to nature writer Robert Macfarlane for Country Life magazine, Kate recalled the advice she received during her treatment and recovery. “I was told in hospital that my recovery would not be linear. There will be good and bad days, that it will take time,” she said.
She compared the recovery process to the natural cycles of rest and renewal, adding, “This is the same in nature. It shows us that periods of rest, reflection and renewal are equally as important as moments of growth.”
The Princess said spending time outdoors had helped her reconnect with herself during a difficult period.
“What I feel really passionate about, having had first-hand experience, is approaching illness and recovery through a whole-person approach. Yes, serious illness creates a lot of physical challenges, but there is also a deeper part to all of us,” she said.
“Nature has allowed me to find a deeper connection to my mind, body and spirit,” she added.
Also read: 'Miracle' Breast Cancer Pill That 'Slows Progression Of Disease' To Be Rolled Out On NHS
Research suggests that spending time in nature may support psychological well-being among people undergoing cancer treatment.
A 2023 scoping review published in International Journal of Environmental Research and Public Health examined 12 studies involving 2,786 cancer survivors. The studies were based on different forms of nature exposure, including walking outdoors, forest therapy, gardening and even experiencing natural environments through virtual reality.
Researchers reported improvements in several areas, including anxiety, depression, sleep, stress, fatigue and pain. Participants also described nature as an important source of comfort while battling cancer.
Another review published in Seminars in Radiation Oncology in July 2026 examined interventions related to nature for adults diagnosed with cancer. It identified benefits like reduced psychological distress, improved mood, sleep, quality of life and social connection.
The review studied interventions like gardening, forest therapy, physical activity in nature, therapeutic landscapes and nature prescriptions.
A cancer diagnosis affects physical as well as mental health. Patients may experience anxiety, depression, fear of recurrence, uncertainty about the future and emotional exhaustion during treatment and recovery. Spending time in nature can help in several ways:
Natural environments can give a break from medical appointments, treatment schedules and daily responsibilities. Research suggests that exposure to green spaces may help reduce psychological distress and improve mood.
Walking in a garden, park or other outdoor space can provide an opportunity for movement. Physical activity, when appropriate to a patient's treatment stage, can help improve physical functioning and reduce fatigue related to treatment.
Gardening groups, nature walks and outdoor activities can help patients reconnect with family members, friends and other people. Social support can be valuable during periods of emotional difficulty.
Outdoor time can encourage relaxation and help establish regular daily routines. Exposure to natural daylight also helps regulate the body's circadian rhythm, which helps sleep-wake pattern.
While research suggests that nature-based activities may support mental health and aspects of quality of life, there is no formidable evidence that spending time outdoors can eliminate cancer risk entirely, shrink tumours or prevent recurrence.
These activities should be viewed as supplementary forms of support, not alternatives to surgery, chemotherapy, radiotherapy, immunotherapy or other prescribed cancer treatments.
It is also important to know that patients may not be able to spend time outdoors during treatment. Fatigue, reduced immunity, mobility limitations, treatment side effects and environmental conditions can affect what is safe and comfortable.
Patients should discuss appropriate physical activity and outdoor exposure with their doctors, especially if they are immunocompromised or recovering from surgery.
Credit: The Jenny McCarthy Wahlberg Show/Youtube
Actress Jenny McCarthy has opened up about the lasting effects of her battle with mold poisoning, revealing that the experience has left her with post-traumatic stress disorder (PTSD), anxiety and a fear of being exposed to mold again.
During a recent episode of her podcast, The Jenny McCarthy-Wahlberg Show, the actress spoke about the physical and emotional toll of the illness, the extensive measures she has taken to avoid further exposure and her ongoing recovery.
McCarthy said she had to discard most of her belongings after the suspected exposure, including her clothes and furniture.
"I wound up throwing everything away," she said, adding that she and her husband, Donnie Wahlberg, also left their furniture behind when they moved out of their Los Angeles home.
Although she believes the exposure may have originated in her makeup room, she said she did not want to take any chances.
Also read: One In Three Hospital Patients With Serious Mould Infections Died, CDC Study Finds
McCarthy said the experience made her fearful of encountering mold wherever she went. She described having histamine reactions in different places and struggling with everyday activities, including travelling in Ubers, visiting restaurants and boarding airplanes.
The actress also revealed that the prolonged health struggles contributed to a nervous breakdown, leaving her husband worried about her well-being.
Having undergone 11 surgeries in 15 months, McCarthy said she became increasingly afraid that her body would start "falling apart again."
She also described the emotional strain of her treatment, which involved taking around 100 pills a day.
"I find myself crying sometimes," she said, describing how difficult it was to manage the medication and the uncertainty surrounding her recovery.
Read More: Cladophialophora bantiana: US CDC Flags Surge In Deadly Brain Fungus Cases
McCarthy first spoke publicly about her health ordeal in March, describing six months of what she called "living hell."
She previously reported experiencing an infected root canal, pus-filled growths on her eyelids, mouth infections, tooth pain, skin rashes and food allergies.
The actress said a doctor diagnosed her with mycotoxin poisoning in December 2025. She has since described being in remission for seven months and focusing on recovery.
Her efforts to avoid further exposure have also been extensive. In an October 29 podcast episode, she revealed that she had been sleeping in a tent in her backyard because she was afraid of being exposed to mold indoors.
"Because I am paranoid now about basically sleeping anywhere, I live in a tent," she said.
McCarthy has also spoken about concerns over her breast implants and whether they could be associated with mold exposure. During a November 3 podcast episode, she discussed the issue with plastic surgeon Dr Terry Dubrow, who has treated her previously.
Mycotoxins are toxic substances produced by certain molds and other fungi. Exposure can occur through contaminated food or environments, depending on the type of toxin and the route of exposure.
According to the Cleveland Clinic, mycotoxin exposure can affect different parts of the body, including the digestive system, eyes and mouth. Mold exposure can also trigger allergic reactions and worsen respiratory conditions such as asthma.
The health effects depend on factors such as the type of mycotoxin, the amount and duration of exposure, and an individual's susceptibility.
Credit: AI image
In a bizarre medical case, a 28-year-old US man began seeing his pet cat Luna’s features on human faces after brain surgery. These included almond-shaped eye sockets enlarged pupils and stripes.
If Karl sees Luna first thing in the morning, he continues to see her features on human faces throughout the day, whether in person or online.
However, if he wakes up looking at a human face, he may see that person’s pupils and eye shape on other people’s faces and even on his cat.
According to a case report published in the journal Cortex, Karl experiences a form of palinopsia, in which something seen earlier persists or reappears in subsequent perception. In his case, this causes facial distortions known as prosopometamorphopsia (PMO).
Also read: Rare Canine Tooth Found In Indian Teen’s Eyelid: What Is An Ectopic Tooth?
Karl, who lives in the northeastern US, has experienced the condition for two years. It began after surgery to remove part of his right temporal lobe to treat an arteriovenous malformation (AVM), an abnormal tangle of blood vessels connecting arteries and veins that can cause bleeding in the brain.
The right temporal lobe plays an important role in face processing.
"This case of Karl seeing his cat's features in human faces and vice versa demonstrates that individual features can be pulled from memory and influence our ongoing perception," said lead author Brad Duchaine, professor and chair of psychological and brain sciences and principal investigator of the Social Perception Lab at Dartmouth.
Karl is not alone. According to Duchaine's lab, more than 250 people experience facial distortions. Many are mistakenly diagnosed with psychiatric problems.
"We have heard from people who have been told that they had a psychiatric problem and, in some cases, have even been put on antipsychotics, when they are in fact just having visual problems," Duchaine said.
Duchaine also cited a 1986 study published in Cortex. It described a woman who saw a poodle sitting on a passenger's lap while riding a bus. She then began seeing the poodle's face on every passenger. The woman had experienced a stroke nine months earlier.
Unlike that case, Karl sees individual facial features transferred between faces rather than entire faces.
Also read: Hours Of Sitting, Gaming And Binge-Watching OTT? Doctors Warn Of Blood Clot Risk In Young People
Duchaine used a large language model to turn a line drawing of Karl’s experience into a photorealistic image. He then worked with Karl to refine the visuals featured in the report.
AI-generated images can help researchers understand visual distortions and help patients explain their experiences to doctors, friends and family, Duchaine said, adding that he will continue working with Karl to decode more about the condition.
Prosopometamorphopsia (PMO) is a rare visual condition in which faces or facial features appear distorted due to changes in the brain's face-processing network. The term combines prosopo (Greek for face) and metamorphopsia (perceptual distortion).
People with PMO may see facial features as:
Two prominent subtypes are:
Most cases last days or weeks, although some persist for years. Around 75 case reports have so far been published.
© $2026 Times Horizon Private Limited